Actinium Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Actinium Pharmaceuticals at ASH 2026 in New Orleans: Booth 2932.
| Organization | ASH 2026 Attendance |
|---|---|
Actinium Pharmaceuticals New York, NY | |
Develops targeted radiotherapies: Actimab-A (CD33) for AML, and Iomab-B and Iomab-ACT (CD45) for transplant and cell therapy conditioning. | Booth Exhibiting at Booth 2932 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Actinium Pharmaceuticals
Tell us what you sell and we’ll find the people at Actinium Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction